Week 3 Cardiovascular Drugs-Understanding Pharmacology-Turley

Front 1

NAME THE CLASSIFICATION, GENERIC, INDICATION FOR:
Humulin

Back 1

insulin
for diabetes mellitis

Front 2

NAME THE CLASSIFICATION, GENERIC, INDICATION FOR:
Diabinese

Back 2

sulfonylureas (1st generation)
chlorpropamide
diabetes type II

Front 3

NAME THE CLASSIFICATION, GENERIC, INDICATION FOR:
Glucotrol, Glucotrol XL

Back 3

sulfonylureas (2nd generation)
glipizide
diabetes type II--lower blood sugar (glucose) by increasing the release of insulin from the pancreas.

Front 4

Quinaglute

Back 4

antiarrhythmic

discontinued

Front 5

Carafate

Back 5

sucralfate
used to treat peptic ulcers

Front 6

Colace

Back 6

docusate
stool softener laxative

Front 7

ferrous sulfate

Back 7

iron supplement

Front 8

methacholine chloride

Back 8

cholinergic, bronchoconstrictor for in vivo pulmonary challenge tests

Front 9

Plavix

Back 9

platelet aggregation inhibitor; prescribed after stent placement to prevent clotting

Front 10

flecainide

Back 10

a sodium channel blocker that decreases the rate of cardiac conduction and increases the ventricular refractory period; used in the treatment of life-threatening arrhythmias.

Front 11

Tensilon

Back 11

an anticholinesterase agent with a duration of action of approximately 10 minutes; used for differential diagnosis and evaluation of treatment requirements in myasthenia gravis and as an antagonist to trademark for a solution of edrophonium chloride.
; nondepolarizing neuromuscular blocking agents (e.g., tubocurarine).

Front 12

Dilantin

Back 12

trademark for preparations of phenytoin.
an anticonvulsant used in the treatment of epilepsy other than the petit mal type, the treatment of status epilepticus, and the prevention and treatment of seizures associated with neurosurgery; administered orally. Called also diphenylhydantoin

Front 13

Diovan

Back 13

valsartan
angiotensin II receptor blocker
dilates blood vessels and decreases blood pressure